GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wockhardt Ltd (BOM:532300) » Definitions » YoY EPS Growth

Wockhardt (BOM:532300) YoY EPS Growth : 115.83% (As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Wockhardt YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Wockhardt's YoY EPS Growth for the quarter that ended in Dec. 2024 was 115.83%.

Wockhardt's Earnings per Share (Diluted) for the three months ended in Dec. 2024 was ₹0.91.

Wockhardt YoY EPS Growth Historical Data

The historical data trend for Wockhardt's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wockhardt YoY EPS Growth Chart

Wockhardt Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 64.44 1,087.50 -135.58 -91.65 17.38

Wockhardt Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.14 18.93 89.76 72.63 115.83

Wockhardt YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Wockhardt's YoY EPS Growth for the fiscal year that ended in Mar. 2024 is calculated as:

YoY EPS Growth (A: Mar. 2024 )
=(Earnings per Share (Diluted) (A: Mar. 2024 )-Earnings per Share (Diluted) (A: Mar. 2023 ))/ | Earnings per Share (Diluted) (A: Mar. 2023 ) |
=(-32.05--38.79)/ | -38.79 |
=17.38 %

Wockhardt's YoY EPS Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EPS Growth (Q: Dec. 2024 )
=(Earnings per Share (Diluted) (Q: Dec. 2024 )-Earnings per Share (Diluted) (Q: Dec. 2023 )) / | Earnings per Share (Diluted) (Q: Dec. 2023 )) |
=(0.91--5.75)/ | -5.75 |
=115.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wockhardt YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Wockhardt's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Wockhardt Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wockhardt Ltd (BOM:532300) » Definitions » YoY EPS Growth
Comparable Companies
BOM:506820 NSE:GLAND BOM:506943 BOM:540596 BOM:544210 BOM:533573 BOM:543635 BOM:543064 BOM:524816 BOM:524558 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
WOCKPHARMA:India
Address
Wockhardt Towers, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Website
https://www.wockhardt.com
Wockhardt Ltd is a drug manufacturing company focusing on pharmaceutical and biotechnology products. The company conducts research in the fields of pharmaceuticals and biotechnology while also operating its chain of Super Specialty Hospitals. The vast majority of the company's revenue is generated in Europe. The company also operates in the USA, Japan, Russia, and Rest of the world.

Wockhardt Headlines

No Headlines